RNF139 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.807800E-01
Normal-vs-Stage2
7.619000E-01
Normal-vs-Stage3
1.776820E-01
Normal-vs-Stage4
9.292200E-01
Stage1-vs-Stage2
7.358400E-01
Stage1-vs-Stage3
5.907600E-01
Stage1-vs-Stage4
6.585800E-01
Stage2-vs-Stage3
4.931800E-01
Stage2-vs-Stage4
8.265200E-01
Stage3-vs-Stage4
4.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.346400E-01
Normal-vs-AfricanAmerican
3.739400E-01
Normal-vs-Asian
4.325400E-01
Caucasian-vs-AfricanAmerican
6.365400E-01
Caucasian-vs-Asian
5.982600E-01
AfricanAmerican-vs-Asian
9.258600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.772600E-01
Normal-vs-Female
9.212200E-01
Male-vs-Female
1.186240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.692960E-01
Normal-vs-Age(41-60Yrs)
8.347400E-01
Normal-vs-Age(61-80Yrs)
3.825000E-01
Normal-vs-Age(81-100Yrs)
2.636000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.702000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.343000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.140800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.824800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.008400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.292200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.612750E-01
Normal-vs-Daily Drinker
4.109400E-01
Normal-vs-Weekly Drinker
4.079400E-01
Normal-vs-Occasional Drinker
6.321000E-01
Normal-vs-Social Drinker
6.809600E-01
Non Drinker-vs-Daily Drinker
5.273000E-01
Non Drinker-vs-Weekly Drinker
5.692200E-01
Non Drinker-vs-Occasional Drinker
4.622200E-02
Non Drinker-vs-Social Drinker
1.596160E-01
Daily Drinker-vs-Weekly Drinker
9.965600E-01
Daily Drinker-vs-Occasional Drinker
7.656400E-02
Daily Drinker-vs-Social Drinker
4.902200E-01
Weekly Drinker-vs-Occasional Drinker
8.121600E-02
Weekly Drinker-vs-Social Drinker
5.282400E-01
Occasional Drinker-vs-Social Drinker
1.486040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.061420E-01
Normal-vs-Grade 2
1.291220E-01
Normal-vs-Grade 3
1.486200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.594000E-02
Grade 1-vs-Grade 3
1.973970E-02
Grade 1-vs-Grade 4
1.061420E-01
Grade 2-vs-Grade 3
8.312600E-01
Grade 2-vs-Grade 4
1.291220E-01
Grade 3-vs-Grade 4
1.486200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.990200E-01
Normal-vs-NonDiabetic
4.995800E-01
Diabetic-vs-NonDiabetic
5.597000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.681000E-01
Normal-vs-NoPancreatitis
5.037400E-01
Pancreatitis-vs-NoPancreatitis
9.338000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.384000E-01
Normal-vs-N1
8.134000E-01
N0-vs-N1
1.857450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.367400E-01
Normal-vs-TP53-NonMutant
2.702000E-01
TP53-Mutant-vs-TP53-NonMutant
8.082400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
